PDL Biopharma Sues to Protect Cardene I.V.

Law360, New York (April 18, 2007, 12:00 AM EDT) -- An Indian pharmaceutical company has been hit with a patent infringement suit over its efforts to move in on the market for PDL Biopharma Inc.’s hypertension treatment Cardene I.V.

PDL Biopharma filed a lawsuit Tuesday in the U.S. District Court for the Eastern District of Michigan against Sun Pharmaceutical Industries Ltd., which is identified in the complaint as a subsidiary of Mumbai-based “Sun India.”

Also on Tuesday, PDL Biopharma filed a suit looking to enforce the same patent against the same defendant in the U.S. District...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.